{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:01:57Z","timestamp":1787688117592,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-018-0984-0","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T07:34:00Z","timestamp":1546500840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand"],"prefix":"10.1186","volume":"19","author":[{"given":"Nattakorn","family":"Songsirisuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veraprapas","family":"Kittipibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilubon","family":"Methachittiphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorawan","family":"Charoenattasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath","family":"Zungsontiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ittikorn","family":"Spanuchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Buppajarntham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charoen","family":"Mankongpaisarnrung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarat","family":"Satitthummanid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphot","family":"Srimahachota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pairoj","family":"Chattranukulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smonporn","family":"Boonyaratavej Songmuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-9947","authenticated-orcid":false,"given":"Sarinya","family":"Puwanant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"10","key":"984_CR1","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","volume":"287","author":"BJ Maron","year":"2002","unstructured":"Maron BJ. Hypertrophic cardiomyopathy: a systematic review. Jama. 2002;287(10):1308\u201320.","journal-title":"Jama"},{"issue":"1","key":"984_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","volume":"64","author":"BJ Maron","year":"2014","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64(1):83\u201399.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"984_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrcardio.2016.140","volume":"13","author":"S Sen-Chowdhry","year":"2016","unstructured":"Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nat Rev Cardiol. 2016;13(11):651\u201375.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"984_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/hrt.33.5.671","volume":"33","author":"DA Swan","year":"1971","unstructured":"Swan DA, Bell B, Oakley CM, Goodwin J. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 1971;33(5):671\u201385.","journal-title":"Br Heart J"},{"issue":"7844","key":"984_CR5","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/S0140-6736(73)92730-X","volume":"2","author":"T Hardarson","year":"1973","unstructured":"Hardarson T, De la Calzada CS, Curiel R, Goodwin JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973;2(7844):1462\u20137.","journal-title":"Lancet"},{"key":"984_CR6","unstructured":"Shah PM, Adelman AG, Wigle ED, Gobel FL, Burchell HB, Hardarson T, Curiel R, De La Calzada C, Oakley CM, Goodwin JF: The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1974, 35(2):suppl II:179\u2013195."},{"issue":"3","key":"984_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","volume":"47","author":"W McKenna","year":"1981","unstructured":"McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47(3):532\u20138.","journal-title":"Am J Cardiol"},{"issue":"2","key":"984_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","volume":"48","author":"BJ Maron","year":"1981","unstructured":"Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981;48(2):252\u20137.","journal-title":"Am J Cardiol"},{"issue":"2","key":"984_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0002-8703(84)90624-0","volume":"108","author":"Y Koga","year":"1984","unstructured":"Koga Y, Itaya K, Toshima H. Prognosis in hypertrophic cardiomyopathy. Am Heart J. 1984;108(2):351\u20139.","journal-title":"Am Heart J"},{"issue":"3","key":"984_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/oxfordjournals.eurheartj.a059689","volume":"11","author":"F Romeo","year":"1990","unstructured":"Romeo F, Pelliccia F, Cristofani R, Martuscelli E, Reale A. Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J. 1990;11(3):233\u201340.","journal-title":"Eur Heart J"},{"issue":"3","key":"984_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0735-1097(10)80176-7","volume":"17","author":"C Seiler","year":"1991","unstructured":"Seiler C, Hess OM, Schoenbeck M, Turina J, Jenni R, Turina M, Krayenbuehl HP. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol. 1991;17(3):634\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"984_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0002-9149(98)00455-X","volume":"82","author":"S Maki","year":"1998","unstructured":"Maki S, Ikeda H, Muro A, Yoshida N, Shibata A, Koga Y, Imaizumi T. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82(6):774\u20138.","journal-title":"Am J Cardiol"},{"issue":"6","key":"984_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/hrt.50.6.530","volume":"50","author":"LM Shapiro","year":"1983","unstructured":"Shapiro LM, Zezulka A. Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital. Br Heart J. 1983;50(6):530\u20133.","journal-title":"Br Heart J"},{"issue":"12","key":"984_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1056\/NEJM198903233201201","volume":"320","author":"P Spirito","year":"1989","unstructured":"Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320(12):749\u201355.","journal-title":"N Engl J Med"},{"issue":"9","key":"984_CR15","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1161\/01.CIR.92.9.2488","volume":"92","author":"CR Cannan","year":"1995","unstructured":"Cannan CR, Reeder GS, Bailey KR, Melton LJ 3rd, Gersh BJ. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation. 1995;92(9):2488\u201395.","journal-title":"Circulation"},{"issue":"6","key":"984_CR16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","volume":"26","author":"F Cecchi","year":"1995","unstructured":"Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995;26(6):1529\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"984_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1378\/chest.114.4.1091","volume":"114","author":"M Kyriakidis","year":"1998","unstructured":"Kyriakidis M, Triposkiadis F, Anastasakis A, Theopistou A, Tocta R, Barbetseas J, Gialafos J. Hypertrophic cardiomyopathy in Greece: clinical course and outcome. Chest. 1998;114(4):1091\u20136.","journal-title":"Chest"},{"issue":"7","key":"984_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jama.281.7.650","volume":"281","author":"BJ Maron","year":"1999","unstructured":"Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. Jama. 1999;281(7):650\u20135.","journal-title":"Jama"},{"issue":"6","key":"984_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","volume":"41","author":"MJ Kofflard","year":"2003","unstructured":"Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol. 2003;41(6):987\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"984_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0002-9149(98)00932-1","volume":"83","author":"BJ Maron","year":"1999","unstructured":"Maron BJ, Schiffers A, Klues HG. Comparison of phenotypic expression of hypertrophic cardiomyopathy in patients from the United States and Germany. Am J Cardiol. 1999;83(4):626\u20137 a610.","journal-title":"Am J Cardiol"},{"issue":"6","key":"984_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jhh.1002006","volume":"20","author":"RL Antikainen","year":"2006","unstructured":"Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ. Department of H, social security hypertension care computer P: left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men? J Hum Hypertens. 2006;20(6):451\u20139.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"984_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cnc.2016.04.002","volume":"28","author":"PR Harris","year":"2016","unstructured":"Harris PR. The Normal electrocardiogram: resting 12-Lead and electrocardiogram monitoring in the hospital. Crit Care Nurs Clin North Am. 2016;28(3):281\u201396.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"6","key":"984_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/ehjci\/jev192","volume":"17","author":"EK Kim","year":"2016","unstructured":"Kim EK, Lee SC, Hwang JW, Chang SA, Park SJ, On YK, Park KM, Choe YH, Kim SM, Park SW, et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging. 2016;17(6):678\u201386.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"984_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u201339 e14.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"984_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/hrt.2007.118018","volume":"94","author":"DH Kwon","year":"2008","unstructured":"Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P, Garcia MJ, Lever HM, Desai MY. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2008;94(10):1295\u2013301.","journal-title":"Heart"},{"issue":"1","key":"984_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0735-1097(92)90057-T","volume":"19","author":"JA Panza","year":"1992","unstructured":"Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19(1):91\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"984_CR27","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.amjcard.2013.02.040","volume":"111","author":"KW Klarich","year":"2013","unstructured":"Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK, Ackerman MJ, Nishimura RA, Tajik AJ, Ommen SR. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2013;111(12):1784\u201391.","journal-title":"Am J Cardiol"},{"issue":"10","key":"984_CR28","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.amjcard.2003.07.027","volume":"92","author":"H Kitaoka","year":"2003","unstructured":"Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003;92(10):1183\u20136.","journal-title":"Am J Cardiol"},{"issue":"7","key":"984_CR29","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1002\/clc.20533","volume":"33","author":"T Hamada","year":"2010","unstructured":"Hamada T, Kubo T, Kitaoka H, Hirota T, Hoshikawa E, Hayato K, Shimizu Y, Okawa M, Yamasaki N, Matsumura Y, et al. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy. Clin Cardiol. 2010;33(7):E24\u20138.","journal-title":"Clin Cardiol"},{"key":"984_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijcard.2016.06.044","volume":"219","author":"Q Ciampi","year":"2016","unstructured":"Ciampi Q, Olivotto I, Gardini C, Mori F, Peteiro J, Monserrat L, Fernandez X, Cortigiani L, Rigo F, Lopes LR, et al. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: the international stress Echo registry. Int J Cardiol. 2016;219:331\u20138.","journal-title":"Int J Cardiol"},{"issue":"2","key":"984_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.echo.2011.11.005","volume":"25","author":"J Peteiro","year":"2012","unstructured":"Peteiro J, Bouzas-Mosquera A, Fernandez X, Monserrat L, Pazos P, Estevez-Loureiro R, Castro-Beiras A. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2012;25(2):182\u20139.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"984_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ehjci\/jeu225","volume":"16","author":"J Peteiro","year":"2015","unstructured":"Peteiro J, Fernandez X, Bouzas-Mosquera A, Monserrat L, Mendez C, Rodriguez-Garcia E, Soler R, Couto D, Castro-Beiras A. Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015;16(4):423\u201332.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"984_CR33","doi-asserted-by":"crossref","unstructured":"Kubo T, Hirota T, Baba Y, Ochi Y, Takahashi A, Yamasaki N, Hamashige N, Yamamoto K, Kondo F, Bando K, et al. Patients' characteristics and clinical course of hypertrophic cardiomyopathy in a regional Japanese cohort- results from Kochi RYOMA study. Circ J. 2018.","DOI":"10.1253\/circj.CJ-17-0845"},{"issue":"4","key":"984_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/clc.20057","volume":"30","author":"CH Lee","year":"2007","unstructured":"Lee CH, Liu PY, Lin LJ, Chen JH, Tsai LM. Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan--a tertiary center experience. Clin Cardiol. 2007;30(4):177\u201382.","journal-title":"Clin Cardiol"},{"issue":"8","key":"984_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","volume":"102","author":"BJ Maron","year":"2000","unstructured":"Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102(8):858\u201364.","journal-title":"Circulation"},{"issue":"12","key":"984_CR36","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0002-9149(93)91111-T","volume":"72","author":"MJ Kofflard","year":"1993","unstructured":"Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol. 1993;72(12):939\u201343.","journal-title":"Am J Cardiol"},{"issue":"4","key":"984_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1536\/ihj.14-418","volume":"56","author":"M Yoshinaga","year":"2015","unstructured":"Yoshinaga M, Yoshikawa D, Ishii H, Hirashiki A, Okumura T, Kubota A, Sakai S, Harada K, Somura F, Mizuno T, et al. Clinical characteristics and long-term outcomes of hypertrophic cardiomyopathy. Int Heart J. 2015;56(4):415\u201320.","journal-title":"Int Heart J"},{"issue":"1","key":"984_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjmed.2003.09.020","volume":"116","author":"HH Ho","year":"2004","unstructured":"Ho HH, Lee KL, Lau CP, Tse HF. Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med. 2004;116(1):19\u201323.","journal-title":"Am J Med"},{"issue":"3","key":"984_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1172\/JCI115061","volume":"87","author":"JK Gwathmey","year":"1991","unstructured":"Gwathmey JK, Warren SE, Briggs GM, Copelas L, Feldman MD, Phillips PJ, Callahan MJ, Schoen FJ, Grossman W, Morgan JP. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest. 1991;87(3):1023\u201331.","journal-title":"J Clin Invest"},{"issue":"25","key":"984_CR40","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","volume":"136","author":"EJ Rowin","year":"2017","unstructured":"Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM, Maron MS, Maron BJ. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation. 2017;136(25):2420\u201336.","journal-title":"Circulation"},{"issue":"21","key":"984_CR41","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517\u201324.","journal-title":"Circulation"},{"issue":"6","key":"984_CR42","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","volume":"8","author":"D Pasqualucci","year":"2015","unstructured":"Pasqualucci D, Fornaro A, Castelli G, Rossi A, Arretini A, Chiriatti C, Targetti M, Girolami F, Corda M, Orru P, et al. Clinical Spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy. Circ Heart Fail. 2015;8(6):1014\u201321.","journal-title":"Circ Heart Fail"},{"key":"984_CR43","doi-asserted-by":"crossref","unstructured":"Rigopoulos AG, Sakellaropoulos S, Ali M, Mavrogeni S, Manginas A, Pauschinger M, Noutsias M. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results. Heart Fail Rev. 2018.","DOI":"10.1007\/s10741-018-9706-z"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0984-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0984-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0984-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:13:22Z","timestamp":1577992402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0984-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0984-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"15 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in a tertiary referral center. The study protocol was approved by the University Institutional Review Board (IRB), Faculty of Medicine, Chulalongkorn University IRB No. 394\/60 or COA No. 827\/2017. The IRB was approved by Emeritus Professor Tada Sueblinvong, MD and Assistant Professor Prapapan Rajatapiti, MD, PhD on September 26, 2017.Not applicable. This is a retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1"}}